AIT Therapeutics Inc Share Price Other OTC
Equities
US50027L1070
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2025 * | 9.67M 762M | Sales 2026 * | 31.61M 2.49B | Capitalization | 28.09M 2.21B |
---|---|---|---|---|---|
Net income 2025 * | -44M -3.47B | Net income 2026 * | -33M -2.6B | EV / Sales 2025 * | 3.21 x |
Net Debt 2025 * | 2.95M 232M | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 0.89 x |
P/E ratio 2025 * |
-0.53
x | P/E ratio 2026 * |
-0.69
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 81.31% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 12/01/17 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 31/08/21 |
Amir Avniel
PSD | President | 50 | 12/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 31/07/15 |
William Forbes
BRD | Director/Board Member | 62 | 12/08/18 |
Erick Lucera
BRD | Director/Board Member | 57 | 09/08/17 |
1st Jan change | Capi. | |
---|---|---|
-6.24% | 180B | |
-6.08% | 99.21B | |
-5.98% | 66.25B | |
-9.35% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.88% | 28.98B | |
-8.38% | 23.5B | |
+16.18% | 24.07B |